Literature DB >> 21145252

Circulating microRNAs: Association with disease and potential use as biomarkers.

Glen Reid1, Michaela B Kirschner, Nico van Zandwijk.   

Abstract

The control of gene expression by microRNAs influences many cellular processes and has been implicated in the control of many (patho)physiological states. Recently, microRNAs have been detected in serum and plasma, and circulating microRNA profiles have now been associated with a range of different tumour types, diseases such as stroke and heart disease, as well as altered physiological states such as pregnancy. Here we review the disease-specific profiles of circulating microRNAs, and the methodologies used for their detection and quantification. We also discuss possible functions of circulating microRNAs and their potential as non-invasive biomarkers.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145252     DOI: 10.1016/j.critrevonc.2010.11.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  201 in total

1.  Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.

Authors:  Moo Yong Park; Sandra M Herrmann; Ahmed Saad; Robert Jay Widmer; Hui Tang; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2014-10-31       Impact factor: 5.992

Review 2.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

Review 3.  Extracellular RNAs: A Secret Arm of Immune System Regulation.

Authors:  Paola de Candia; Veronica De Rosa; Maurizio Casiraghi; Giuseppe Matarese
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

4.  STAT1 regulates MD-2 expression in monocytes of sepsis via miR-30a.

Authors:  Yanhong Wang; Tiehua Li; Benquan Wu; Hui Liu; Jinmei Luo; Dingyun Feng; Yunfeng Shi
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.

Authors:  Yan Zhao; Kai Zhang; Haifeng Jiang; Jiang Du; Zong Na; Wei Hao; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

Review 6.  MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets.

Authors:  Glen Reid
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

Review 7.  microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.

Authors:  Christian Schulte; Tanja Zeller
Journal:  Cardiovasc Diagn Ther       Date:  2015-02

8.  Circulating microRNA-23b as a new biomarker for rheumatoid arthritis.

Authors:  Xi Liu; Su Ni; Chenkai Li; Nanwei Xu; Wenyang Chen; Min Wu; Andre J van Wijnen; Yuji Wang
Journal:  Gene       Date:  2019-06-06       Impact factor: 3.688

Review 9.  Potential relevance of microRNAs in inter-species epigenetic communication, and implications for disease pathogenesis.

Authors:  Pál Perge; Zoltán Nagy; Ábel Decmann; Ivan Igaz; Peter Igaz
Journal:  RNA Biol       Date:  2016-10-28       Impact factor: 4.652

10.  Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.

Authors:  Jingting Wang; Yandong Zhou; Jianguang Lu; Yanan Sun; Hui Xiao; Ming Liu; Linli Tian
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.